Schwannoma

Revision as of 19:11, 14 May 2019 by Aditya Ganti (talk | contribs)
Jump to navigation Jump to search

For patient information click here

Schwannoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Schwannoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Schwannoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Schwannoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Schwannoma

CDC on Schwannoma

Schwannoma in the news

Blogs on Schwannoma

Directions to Hospitals Treating Schwannoma

Risk calculators and risk factors for Schwannoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Synonyms and keywords: Neurilemmoma, Neurinoma, Neurolemmoma, Schwann cell tumor, Schwannomatosis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Schwannoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

WikiDoc Resources for Schwannoma

Articles

Most recent articles on Schwannoma

Most cited articles on Schwannoma

Review articles on Schwannoma

Articles on Schwannoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Schwannoma

Images of Schwannoma

Photos of Schwannoma

Podcasts & MP3s on Schwannoma

Videos on Schwannoma

Evidence Based Medicine

Cochrane Collaboration on Schwannoma

Bandolier on Schwannoma

TRIP on Schwannoma

Clinical Trials

Ongoing Trials on Schwannoma at Clinical Trials.gov

Trial results on Schwannoma

Clinical Trials on Schwannoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Schwannoma

NICE Guidance on Schwannoma

NHS PRODIGY Guidance

FDA on Schwannoma

CDC on Schwannoma

Books

Books on Schwannoma

News

Schwannoma in the news

Be alerted to news on Schwannoma

News trends on Schwannoma

Commentary

Blogs on Schwannoma

Definitions

Definitions of Schwannoma

Patient Resources / Community

Patient resources on Schwannoma

Discussion groups on Schwannoma

Patient Handouts on Schwannoma

Directions to Hospitals Treating Schwannoma

Risk calculators and risk factors for Schwannoma

Healthcare Provider Resources

Symptoms of Schwannoma

Causes & Risk Factors for Schwannoma

Diagnostic studies for Schwannoma

Treatment of Schwannoma

Continuing Medical Education (CME)

CME Programs on Schwannoma

International

Schwannoma en Espanol

Schwannoma en Francais

Business

Schwannoma in the Marketplace

Patents on Schwannoma

Experimental / Informatics

List of terms related to Schwannoma


Overview

Schwannomatosis is one form of a genetic disorder called Neurofibromatosis (NF) that has only recently been recognized. It is a rare disorder, affecting only around 1:40,000 individuals.

Symptoms

  • Schwannomas occur instead of Neurofibromas.
  • Multiple Schwannomas occur.
  • The Schwannomas develop on cranial, spinal and peripheral nerves.
  • Chronic pain, and sometimes numbness, tingling and weakness.
  • About 1/3 of patients have segmental Schwannomatosis, which means that the Schwannomas are limited to a single part of the body, such as an arm, a leg or the spine.
  • There are several cases where people with Schwannomatosis have developed a vestibular Schwannoma (acoustic neuroma).
  • Patients with Schwannomatosis do not have learning disabilities related to the disease.
  • Symptoms are generally brought on by hormonal changes such as puberty and pregnancy.

Cause

  • Like the NF1 and NF2 genes, the candidate Schwannomatosis gene, named INI1, is a tumor suppressor that regulates cell cycle, growth and differentiation. INI1 is also known as SMARCB1, hSNF5, or BAF47, and lies on human Chromosome 22. INI1 is also mutated in other tumors including malignant brain & kidney tumors in infants.
  • Schwannomatosis is known to be a genetic disorder, however it can skip generations.

Treatment

  • If feasible, the Schwannomas can be surgically removed. Any tumor-associated pain usually subsides after tumor removal. Damaged nerves and scar tissue can be a result of surgery and pain can be an ongoing problem.
  • Sometimes, a tumor will reappear at the same site after surgery.
  • If surgery is unfeasible, then pain management will have to be used. Schwannomatosis can sometimes cause severe, untreatable pain over time.
  • Other than surgery and/or pain management, there are no other medical treatments available. There are no drugs available to treat Schwannomatosis.
  • Gamma knife surgery can be performed on head tumors to help slow growth of a tumor, although there is no guarantee that it will work.
  • Recently, many advances are being made in the treatment of schwannomas. Of interest is CyberKnife, manufactured by Accuray. Success rates, although limited in data, appear to be in the low to mid ninety percent range.

Template:WikiDoc Sources

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

Template:Nervous tissue tumors


Template:WikiDoc Sources